DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia

Information source: National Cancer Institute (NCI)
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Leukemia

Intervention: anti-thymocyte globulin (Drug); cyclophosphamide (Drug); cytarabine (Drug); fludarabine phosphate (Drug); isotretinoin (Drug); tipifarnib (Drug); allogeneic bone marrow transplantation (Procedure); radiation therapy (Procedure); umbilical cord blood transplantation (Procedure)

Phase: Phase 2

Status: Completed

Sponsored by: Children's Oncology Group

Official(s) and/or principal investigator(s):
Robert P. Castleberry, MD, Study Chair, Affiliation: Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham

Summary

RATIONALE: Giving chemotherapy drugs, such as R115777, isotretinoin, cytarabine, and fludarabine, before a donor bone marrow transplant or an umbilical cord transplant helps stop the growth of cancer cells. It also helps stop the patient's immune system from rejecting the donor's stem cells. When the healthy stem cells from a donor are infused into the patient they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets.

PURPOSE: This phase II trial is studying how well giving combination chemotherapy together with donor bone marrow or umbilical cord blood transplant works in treating children with newly diagnosed juvenile myelomonocytic leukemia.

Clinical Details

Official title: Phase II Window Evaluation of the Farnesyl Transferase Inhibitor (R115777) Followed by 13-CIS Retinoic Acid, Cytosine Arabinoside and Fludarabine Plus Hematopoietic Stem Cell Transplantation in Children With Juvenile Myelomonocytic Leukemia

Study design: Treatment

Primary outcome:

Response rate

Safety and tolerability

Toxicity

Event-free survival at 2 years

Prognostic factors

Detailed description: OBJECTIVES:

- Determine the response rate of children with newly diagnosed juvenile myelomonocytic

leukemia treated with R115777, isotretinoin, cytarabine, and fludarabine followed by allogeneic bone marrow or umbilical cord blood transplantation. (R11577 portion of the study closed to accrual as of 08/2005)

- Determine the safety and toxicity of this regimen in these patients.

- Determine the tolerability of this regimen in these patients.

- Determine the rate of 2-year event-free survival of patients treated with this regimen.

- Determine whether prognostic subsets of these patients can be identified based on

expression of clinical, genetic (NFI, monosomy 7, RAS gene), or hematopoietic characteristics.

OUTLINE: This is a multicenter study.

Patients may choose to receive upfront window induction therapy with oral R115777 twice daily on days 1-21. Treatment repeats every 28 days for 2 courses in the absence of disease progression or unacceptable toxicity. Patients with progressive disease or stable disease with unacceptable hematopoietic recovery after 1 course proceed to induction chemotherapy. (R11577 portion of the study closed to accrual as of 08/2005)

All patients receive induction chemotherapy comprising oral isotretinoin once daily beginning on day 1 and fludarabine IV over 30 minutes and cytarabine IV over 4 hours on days 1-5. Treatment with fludarabine and cytarabine repeats every 28 days for 2 courses. Treatment with isotretinoin continues until allogeneic bone marrow or umbilical cord blood transplantation. Patients with progressive disease after 1 course proceed to transplantation.

After completion of isotretinoin, patients receive a preparative regimen comprising total

body irradiation twice daily on days - 7 to -4, cyclophosphamide IV over 2 hours on days -3

and - 2, and anti-thymocyte globulin IV over 4-6 hours every 12 hours on days -3 to -1.

Patients undergo allogeneic bone marrow or umbilical cord blood transplantation on day 0. Patients receive oral isotretinoin daily beginning on approximately day 60 and continuing for 1 year.

Patients are followed every 6 months for 5 years and then annually thereafter.

PROJECTED ACCRUAL: A maximum of 100 patients (18-46 receiving R115777 with induction chemotherapy [R11577 portion of the study closed to accrual as of 08/2005] and 27-54 receiving induction chemotherapy only) will be accrued for this study within 3. 2 years.

Eligibility

Minimum age: N/A. Maximum age: 18 Years. Gender(s): Both.

Criteria:

DISEASE CHARACTERISTICS:

- Newly diagnosed, previously untreated juvenile myelomonocytic leukemia

- Presenting with all of the following:

- Absence of t(9;22) or bcr/abl by PCR

- Absolute monocyte count greater than 1,000/mm^3

- Less than 20% bone marrow blasts

- Presenting with at least 2 of the following:

- Elevated F hemoglobin

- Myeloid precursors in peripheral blood

- WBC greater than 10,000/mm^3

- Sargramostim (GM-CSF) hypersensitivity

PATIENT CHARACTERISTICS:

Age:

- Child

Performance status:

- Not specified

Life expectancy:

- Not specified

Hematopoietic:

- See Disease Characteristics

Hepatic:

- Bilirubin no greater than 2. 0 mg/dL

- ALT no greater than 3 times normal

Renal:

- Creatinine no greater than 2 times normal

PRIOR CONCURRENT THERAPY:

Biologic therapy:

- No concurrent sargramostim (GM-CSF)

Chemotherapy:

- Not specified

Endocrine therapy:

- Not specified

Radiotherapy:

- Not specified

Surgery:

- Not specified

Other:

- No concurrent proton pump inhibitors

Locations and Contacts

Starship Children's Health, Auckland 1, New Zealand

San Jorge Children's Hospital, Santurce 00912, Puerto Rico

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama 35294, United States

Alberta Children's Hospital, Calgary, Alberta T3B 6A8, Canada

Phoenix Children's Hospital, Phoenix, Arizona 85016-7710, United States

Children's & Women's Hospital of British Columbia, Vancouver, British Columbia V6H 3V4, Canada

Children's Hospital and Health Center - San Diego, San Diego, California 92123-4282, United States

Children's Hospital and Research Center - Oakland, Oakland, California 94609-1809, United States

Children's Hospital Central California, Madera, California 93638-8762, United States

Children's Hospital of Orange County, Orange, California 92868, United States

Jonathan Jaques Children's Cancer Center at Miller Children's Hospital, Long Beach, California 90801, United States

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California 90095-1781, United States

Kaiser Permanente Medical Center - Oakland, Sacramento, California 95825, United States

Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda, California 92354, United States

Southern California Permanente Medical Group, Downey, California 90242-2814, United States

Stanford Comprehensive Cancer Center at Stanford University Medical Center, Stanford, California 94305, United States

Sutter Cancer Center, Sacramento, California 95816, United States

UCSF Comprehensive Cancer Center, San Francisco, California 94115, United States

University of California Davis Cancer Center, Sacramento, California 95817, United States

Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center, Farmington, Connecticut 06360-2875, United States

Children's National Medical Center, Washington, District of Columbia 20010-2970, United States

Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, District of Columbia 20007, United States

All Children's Hospital, St. Petersburg, Florida 33701, United States

Kaplan Cancer Center at St. Mary's Medical Center, West Palm Beach, Florida 33407, United States

Memorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida 33021, United States

Nemours Children's Clinic - Orlando, Orlando, Florida 32806, United States

Nemours Children's Clinic, Jacksonville, Florida 32207, United States

Sacred Heart Cancer Center at Sacred Heart Hospital, Pensacola, Florida 32504, United States

St. Joseph's Cancer Institute at St. Joseph's Hospital, Tampa, Florida 33607, United States

University of Florida Shands Cancer Center, Gainesville, Florida 32610-0232, United States

Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah, Georgia 31403-3089, United States

Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, United States

Cancer Care Center at Advocate Lutheran Hospital, Park Ridge, Illinois 60068-1174, United States

Indiana University Cancer Center, Indianapolis, Indiana 46202-5289, United States

Blank Children's Hospital, Des Moines, Iowa 50309, United States

Kosair Children's Hospital, Louisville, Kentucky 40232, United States

Markey Cancer Center at University of Kentucky Chandler Medical Center, Lexington, Kentucky 40536-0293, United States

Children's Hospital of New Orleans, New Orleans, Louisiana 70118, United States

CancerCare of Maine at Eastern Maine Medial Center, Bangor, Maine 04401, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231-2410, United States

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan 48201-1379, United States

Breslin Cancer Center at Ingham Regional Medical Center, Lansing, Michigan 48910, United States

C.S. Mott Children's Hospital at University of Michigan, Ann Arbor, Michigan 48109-0238, United States

CCOP - Kalamazoo, Kalamazoo, Michigan 49007-5341, United States

Hurley Medical Center, Flint, Michigan 48503, United States

Spectrum Health Hospital - Butterworth Campus, Grand Rapids, Michigan 49503-2560, United States

Van Elslander Cancer Center at St. John Hospital and Medical Center, Grosse Pointe Woods, Michigan 48236, United States

Children's Hospitals and Clinics of Minneapolis, Minneapolis, Minnesota 55404, United States

Mayo Clinic Cancer Center, Rochester, Minnesota 55905, United States

University of Minnesota Medical Center & Children's Hospital - Fairview, Minneapolis, Minnesota 55455, United States

University of Mississippi Medical Center, Jackson, Mississippi 39216-4505, United States

Children's Mercy Hospital, Kansas City, Missouri 64108, United States

Siteman Cancer Center at Barnes-Jewish Hospital, St. Louis, Missouri 63110, United States

UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha, Nebraska 68198-6805, United States

Sunrise Hospital and Medical Center, Las Vegas, Nevada 89109-2306, United States

Hackensack University Medical Center Cancer Center, Hackensack, New Jersey 07601, United States

Newark Beth Israel Medical Center, Newark, New Jersey 07112, United States

University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico 87131-5636, United States

Prince of Wales Private Hospital, Randwick, New South Wales 2031, Australia

Albert Einstein Cancer Center at Albert Einstein College of Medicine, Bronx, New York 10461, United States

James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York 14642, United States

Mount Sinai Medical Center, New York, New York 10029, United States

New York Medical College, Valhalla, New York 10595, United States

Roswell Park Cancer Institute, Buffalo, New York 14263-0001, United States

Stony Brook University Cancer Center, Stony Brook, New York 11794-8174, United States

SUNY Upstate Medical University Hospital, Syracuse, New York 13210, United States

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina 27599-7295, United States

CCOP - MeritCare Hospital, Fargo, North Dakota 58122, United States

IWK Health Centre, Halifax, Nova Scotia B3K 6R8, Canada

Children's Hospital Medical Center of Akron, Akron, Ohio 44308-1062, United States

Children's Medical Center - Dayton, Dayton, Ohio 45404-1815, United States

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039, United States

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio 44195-5217, United States

Rainbow Babies and Children's Hospital, Cleveland, Ohio 44106-5000, United States

Toledo Hospital, Toledo, Ohio 43606, United States

Oklahoma University Medical Center, Oklahoma City, Oklahoma 73104, United States

Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada

Oregon Health & Science University Cancer Institute, Portland, Oregon 97239-3098, United States

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-9786, United States

Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, United States

Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033-0850, United States

Hopital Sainte Justine, Montreal, Quebec H3T 1C5, Canada

Montreal Children's Hospital at McGill University Health Center, Montreal, Quebec H3H 1P3, Canada

Royal Children's Hospital, Herston, Brisbane, Queensland 4029, Australia

Saskatoon Cancer Centre at the University of Saskatchewan, Saskatoon, Saskatchewan S7N 4H4, Canada

Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina 29425, United States

East Tennessee Children's Hospital, Knoxville, Tennessee 37916, United States

East Tennessee State University Cancer Center at Johnson City Medical Center, Johnson City, Tennessee 37604, United States

St. Jude Children's Research Hospital, Memphis, Tennessee 38105, United States

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee 37232-6310, United States

CCOP - Scott and White Hospital, Temple, Texas 76508, United States

Children's Hospital of Austin, Austin, Texas 78701, United States

Cook Children's Medical Center - Fort Worth, Fort Worth, Texas 76104-9958, United States

Covenant Children's Hospital, Lubbock, Texas 79410, United States

Methodist Children's Hospital of South Texas, San Antonio, Texas 78229-3993, United States

Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas 75390, United States

Texas Tech University Health Sciences Center School of Medicine - Amarillo, Amarillo, Texas 79106, United States

University of Texas Health Science Center at San Antonio, San Antonio, Texas 78207, United States

Fletcher Allen Health Care - University Health Center Campus, Burlington, Vermont 05405, United States

Children's Hospital of The King's Daughters, Norfolk, Virginia 23507-1971, United States

INOVA Fairfax Hospital, Fairfax, Virginia 22031, United States

Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia 23298-0037, United States

Princess Margaret Hospital for Children, Perth, Western Australia 6001, Australia

Marshfield Clinic - Marshfield Center, Marshfield, Wisconsin 54449, United States

Midwest Children's Cancer Center, Milwaukee, Wisconsin 53226, United States

Additional Information

Clinical trial summary from the National Cancer Institute's PDQ® database

Starting date: June 2001
Last updated: May 23, 2008

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008